EJNMMI Reports

Aims and scope

EJNMMI Reports is the inclusive science journal of the EJNMMI journal family. It is a peer-reviewed open access journal, following international research integrity standards.

The editorial process of EJNMMI Reports does not focus on the extent of the advance of the submitted papers. All valid research with clinical and translational relevance in the field of Nuclear Medicine (including longer and brief reports, negative and positive results, provocative topics, data & protocol descriptors) will be considered, see formats considered below.

EJNMMI Reports publishes scientific articles that are of interest to the nuclear medicine and molecular imaging community and cover diagnostics and therapy within all subfields in this subject area. The journal aims at providing clinical as well as scientific information that is useful for all relevant imaging and clinical communities as well as allied professions.

The journal considers various article types like original research articles, brief communications on novel preliminary approaches, reports on originals, case reports, pictorial essays, reviews and educational material, guidelines published by experts from different clinical and research disciplines, editorials, and letters to the editor.

Important Note
Since January 1^st, 2024 the European Journal of Hybrid Imaging changed its title and is now EJNMMI Reports. Please note that the journal has an impact factor and the impact factor 2023 is 1.7.

The impact factor is currently still found in Clarivate’s JCR/ESCI under the previous title European Journal of Hybrid Imaging. According to the definition of the impact factor the new title EJNMMI Reports will only be reflected, when published content as of 2024 is included into the impact factor calculation.
Based on that procedure the journal will have “half” an impact factor in 2025 under European Journal of Hybrid Imaging and “half” an impact factor under EJNMMI Reports.
In 2026 there will be the full impact factor under EJNMMI Reports, and no longer one for European Journal of Hybrid Imaging.

ANNOUNCEMENT - Call for candidates: Editor-in-Chief for EJNMMI Reports

EJNMMI Reports is searching for a new Editor-in-Chief.

Please find the call for candidates here.

EJNMMI Family Announcement - Call for candidates: Editor-in-Chief for EJNMMI Research

The EJNMMI Family is searching a new Editor-in-Chief for EJNMMI Research.

Please find the call for candidates here.

Thematic Collections: Call for Papers

Quantitative PET in Multidisciplinary Clinical Assessment (Editors: Kelei He (PhD) & Tao Zhou (PhD))

Histopathological Correlations in Nuclear Medicine Imaging (Editors: Elisabeth Eppard, PhD, Yongkang Gai, PhD & Yi-Hsiu Chung, PhD)

Role of Radiopharmaceutical Agents in Cancer theranostics (Editors: Else A. Aalbersberg, Dr.med, & Simone U. Dalm, PhD)

Clinical value of PET with Gallium-labelled Radiopharmaceuticals (Editors: Asim Afaq, MD & Shao-Bo Yao, PhD)

PET imaging and Theragnostic in neuro-oncology (Editors: Silvia Morbelli, PhD & Nelleke Tolboom, PhD)

Brain metabolism, neuropathology and neurodegeneration (Editors: Matteo Bauckneht, PhD, & Guido Rovera, M.D.)

Articles

First-in-human experience of radiopharmaceutical therapy with [¹⁷⁷Lu]Lu-DOTATATE in patients with advanced multiple myeloma

Authors: Wendy Delbart, Marie Vercruyssen, Rachele Danieli, Clémentine Marin, Zéna Wimana, Nathalie Meuleman, Patrick Flamen, Erwin Woff and Ioannis Karfis

Content type: Case report 28 July 2025
Ultra-low dose imaging in a standard axial field-of-view PET

Authors: Thiago Lima, Carlos Vinícius Gomes, Paul Fargier, Klaus Strobel and Antoine Leimgruber

Content type: Short communication 21 July 2025
Call for candidates: Editor-in-Chief for EJNMMI Reports

Authors:

Content type: Announcement 12 July 2025
Lung shunting and radiation pneumonitis after holmium-166 TARE: a case study

Authors: Meike W. M. van Wijk, Marcel J. R. Janssen, Mark J. Arntz, Bram H. J. Geurts, Laura A. Michon, Eric T. T. L. Tjwa, Joey Roosen and J. Frank W. Nijsen

Content type: Case report 8 July 2025
Myocardium-to-cavity ratio derived from simultaneous ^99mTc-PYP/²⁰¹Tl dual-isotope SPECT imaging to differentially diagnose transthyretin cardiac amyloidosis

Authors: Shozo Yamashita, Kenichi Nakajima, Teppei Kitano, Hiromu Kato, Tatsuya Yoneyama, Haruki Yamamoto and Kunihiko Yokoyama

Content type: Original article 1 July 2025

Most recent articles RSS

View all articles

Non-FDG PET/CT in Diagnostic Oncology: a pictorial review

Authors: Francesco Giammarile, Paolo Castellucci, Rudi Dierckx, Enrique Estrada Lobato, Mohsen Farsad, Roland Hustinx, Amirreza Jalilian, Olivier Pellet, Susana Rossi and Diana Paez

Content type: Review 29 November 2019
EANM procedural guidelines for myocardial perfusion scintigraphy using cardiac-centered gamma cameras

Authors: Fabien Hyafil, Alessia Gimelli, Riemer H. J. A. Slart, Panagiotis Georgoulias, Christoph Rischpler, Mark Lubberink, Roberto Sciagra, Jan Bucerius, Denis Agostini and Hein J. Verberne

Content type: Guideline 2 July 2019
Ground glass pulmonary nodules: their significance in oncology patients and the role of computer tomography and 18F–fluorodeoxyglucose positron emission tomography

Authors: Laura Evangelista, Annalori Panunzio, Elena Scagliori and Paolo Sartori

Content type: Original article 26 February 2018
Prostate-specific membrane antigen positron emission tomography (PSMA-PET) for local staging of prostate cancer: a systematic review and meta-analysis

Authors: Sungmin Woo, Soleen Ghafoor, Anton S. Becker, Sangwon Han, Andreas G. Wibmer, Hedvig Hricak, Irene A. Burger, Heiko Schöder and Hebert Alberto Vargas

Content type: Original article 9 September 2020
PET/MRI: a frontier in era of complementary hybrid imaging

Authors: Sikkandhar Musafargani, Krishna Kanta Ghosh, Sachin Mishra, Pachaiyappan Mahalakshmi, Parasuraman Padmanabhan and Balázs Gulyás

Content type: Review 25 June 2018

Most accessed articles RSS

View all articles

Need help with APC funding?

We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here.

Check if your institution is a BMC member

More than 500 institutions have partnered with BMC through the membership program. As an affiliated Author from a member institution, you may be entitled to submit your manuscript without paying the article processing charge (APC) or with a discount. Check here if your institution is a member!

The EJNMMI Journal Family

Neuer Inhalt

Additional information about the EJNMMI group of journals can be found on the EJNMMI Journal Family webpage.